109 related articles for article (PubMed ID: 23546985)
1. Meta-analysis demonstrates lack of a relationship between XRCC1-399 gene polymorphisms and susceptibility to hepatocellular carcinoma.
Zeng XY; Huang JM; Xu JW; Xu Y; Yu HP; Ji L; Qiu XQ
Genet Mol Res; 2013 Jun; 12(2):1916-23. PubMed ID: 23546985
[TBL] [Abstract][Full Text] [Related]
2. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis.
Liu F; Li B; Wei Y; Yan L; Wen T; Zhao J; Xu M
Liver Int; 2011 Jul; 31(6):802-9. PubMed ID: 21645210
[TBL] [Abstract][Full Text] [Related]
3. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
Xie T; Wang ZG; Zhang JL; Liu H
World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255
[TBL] [Abstract][Full Text] [Related]
4. Study on the DNA repair gene XRCC1 and XRCC3 polymorphism in prediction and prognosis of hepatocellular carcinoma risk.
Han X; Xing Q; Li Y; Sun J; Ji H; Huazheng P; Jun L
Hepatogastroenterology; 2012 Oct; 59(119):2285-9. PubMed ID: 22456434
[TBL] [Abstract][Full Text] [Related]
5. The XRCC1 Arg399Gln genetic polymorphism contributes to hepatocellular carcinoma susceptibility: an updated meta-analysis.
Pan Y; Zhao L; Chen XM; Gu Y; Shen JG; Liu LM
Asian Pac J Cancer Prev; 2013; 14(10):5761-7. PubMed ID: 24289575
[TBL] [Abstract][Full Text] [Related]
6. Association between a single nucleotide polymorphism of the XRCC1 gene and hepatocellular carcinoma susceptibility in the Chinese Han population.
Li XF; Chen YX; Ye WW; Tao XF; Zhu JH; Wu S; Lou LQ
Genet Mol Res; 2014 Jan; 13(1):160-6. PubMed ID: 24446299
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of DNA repair gene XRCC1 and hepatocellular carcinoma risk among East Asians: a meta-analysis.
Li J; Li Z; Feng L; Guo W; Zhang S
Tumour Biol; 2013 Feb; 34(1):261-9. PubMed ID: 23055199
[TBL] [Abstract][Full Text] [Related]
8. Association between XRCC1 Arg280His polymorphism and risk of hepatocellular carcinoma: a systematic review and meta-analysis.
Xu W; Liu SA; Li L; Shen ZY; Wu YL
Genet Mol Res; 2015 Jun; 14(2):7122-9. PubMed ID: 26125922
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms of CYP2E1 and DNA repair genes HOGG1 and XRCC1: association with hepatitis B related advanced liver disease and cancer.
Bose S; Tripathi DM; Sukriti ; Sakhuja P; Kazim SN; Sarin SK
Gene; 2013 May; 519(2):231-7. PubMed ID: 23454624
[TBL] [Abstract][Full Text] [Related]
10. An updated meta-analysis between the association of XRCC1 Arg399Gln polymorphism and hepatocellular carcinoma risk.
Zhang XL; Lu Y; Yang S; Peng QL; Wang J; Xie L; Deng Y; He Y; Li TJ; Qin X; Li S
Asian Pac J Cancer Prev; 2014; 15(7):3273-8. PubMed ID: 24815482
[TBL] [Abstract][Full Text] [Related]
11. An updated meta-analysis on the association of X-ray repair cross complementing group 1 codon 399 polymorphism with hepatocellular carcinoma risk.
Wang YD; Zhai WL; Wang HY; Xia XQ
Asian Pac J Cancer Prev; 2014; 15(11):4443-8. PubMed ID: 24969866
[TBL] [Abstract][Full Text] [Related]
12. No association between hOGG1 Ser326Cys polymorphism and hepatocellular carcinoma.
Zhen-Bo T; An-Lin F; Ling L; Su-Fang Z
Hepatogastroenterology; 2013; 60(125):1101-4. PubMed ID: 23186590
[TBL] [Abstract][Full Text] [Related]
13. The association of six non-synonymous variants in three DNA repair genes with hepatocellular carcinoma risk: a meta-analysis.
Shi YH; Wang B; Xu BP; Jiang DN; Zhao DM; Ji MR; Zhou L; Li X; Lu CZ
J Cell Mol Med; 2016 Nov; 20(11):2056-2063. PubMed ID: 27306318
[TBL] [Abstract][Full Text] [Related]
14. DNA-repair and carcinogen-metabolising enzymes genetic polymorphisms as an independent risk factor for hepatocellular carcinoma in Caucasian liver-transplanted patients.
Borentain P; Gérolami V; Ananian P; Garcia S; Noundou A; Botta-Fridlund D; Le Treut YP; Bergé-Lefranc JL; Gérolami R
Eur J Cancer; 2007 Nov; 43(17):2479-86. PubMed ID: 17870518
[TBL] [Abstract][Full Text] [Related]
15. XRCC1 Arg399Gln genetic polymorphism and the risk of hepatocellular carcinoma: a meta-analysis.
Qi Y; Cui L; Song Y; Li N
Mol Biol Rep; 2014 Feb; 41(2):879-87. PubMed ID: 24390232
[TBL] [Abstract][Full Text] [Related]
16. The XRCC1 Arg280His gene polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Li LP; Wu W; Li XH; Song SS
Asian Pac J Cancer Prev; 2013; 14(3):2033-6. PubMed ID: 23679314
[TBL] [Abstract][Full Text] [Related]
17. Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma.
Chen CC; Yang SY; Liu CJ; Lin CL; Liaw YF; Lin SM; Lee SD; Chen PJ; Chen CJ; Yu MW
Int J Epidemiol; 2005 Dec; 34(6):1310-8. PubMed ID: 16172101
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms of XRCC1 gene and susceptibility to hepatocellular carcinoma in Chinese population.
Jiang T; Cui L; Chen L; Liu Z; Ren H
Med Oncol; 2014 Apr; 31(4):887. PubMed ID: 24570146
[TBL] [Abstract][Full Text] [Related]
19. New sights on the associations between the XRCC1 gene polymorphisms and hepatocellular carcinoma susceptibility.
Cai W; Liu X; Li Y; Bi B; Liu L; Wang Z
J Cell Biochem; 2020 Feb; 121(2):1005-1022. PubMed ID: 31478224
[TBL] [Abstract][Full Text] [Related]
20. Association of HLA-DRB1 gene polymorphisms with hepatocellular carcinoma risk: a meta-analysis.
Liu L; Guo W; Zhang J
Minerva Med; 2017 Apr; 108(2):176-184. PubMed ID: 27808488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
